Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer-Reference-Cited by-同舟云学术

Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer

Published:2017-09-05 Issue:8 Volume:35 Page:519-534
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Siemann D. W.¹,Chaplin D. J.²,Horsman M. R.³

Affiliation:

1. Department of Radiation Oncology, University of Florida, Gainesville, FL, USA

2. Mateon Therapeutics, South San Francisco, CA, USA

3. Department of Experimental Clinical Oncology, Aarhus University, Denmark

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2017.1364745

Reference164 articles.

1. Tumor Angiogenesis: Therapeutic Implications

2. Fundamental Concepts of the Angiogenic Process

3. Pathophysiological Basis for the Formation of the Tumor Microenvironment

4. Imaging of angiogenesis: from microscope to clinic

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Tumor Vascular Supply to Enhance Radiation Therapy Administered in Single or Clinically Relevant Fractionated Schedules;International Journal of Molecular Sciences;2024-07-24

2. A study protocol for an open‐label, single‐arm, single‐center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma;Thoracic Cancer;2024-01-11

3. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers;Frontiers in Cell and Developmental Biology;2023-10-03

4. Emerging nanotechnological approaches to regulating tumor vasculature for cancer therapy;Journal of Controlled Release;2023-10

5. Evaluation of breast cancer malignancy, prognostic factors and molecular subtypes using a continuous-time random-walk MR diffusion model;European Journal of Radiology;2023-09